Ahn; Dae Ro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ahn; Dae Ro.The latest application filed is for "novel tracrrna system for cas9".

Company Profile

2.8.15

Ahn; Dae Ro - Seoul KR
Ahn; Dae Ro - Paju-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Drug carrier having self-assembled 3-D nucleic acid nanostructure Grant 11,446,254 - Ahn , et al. September 20, 2	2022-09-20
Novel tracrRNA system for Cas9 App 20220090065 - AHN; Dae-Ro ; et al.	2022-03-24
Self-assembled ribonucleoprotein nanoparticles Grant 11,129,907 - Ahn , et al. September 28, 2	2021-09-28
Lung-specific Drug Delivery System Consisting Of Oligonucleotide Polymers And Biocompatible Cationic Peptides For The Prevention Or Treatment Of Pulmonary Fibrosis And Use Thereof App 20210130831 - AHN; Dae-Ro ; et al.	2021-05-06
Three-dimensional Self-assembled Nucleic Acid Nanoparticles And Use Thereof App 20210128748 - AHN; Dae-Ro ; et al.	2021-05-06
Method of packing polynucleotides Grant 10,793,889 - Ahn , et al. October 6, 2	2020-10-06
Drug Carrier Having Self-assembled 3-d Nucleic Acid Nanostructure App 20190365659 - AHN; Dae Ro ; et al.	2019-12-05
Self-assembled Ribonucleoprotein Nanoparticles App 20180169270 - AHN; Dae Ro ; et al.	2018-06-21
Method Of Packing Polynucleotides App 20180105852 - AHN; Dae Ro ; et al.	2018-04-19
Drug carrier having L-DNA nanocage structure Grant 9,919,001 - Ahn March 20, 2	2018-03-20
Contrast medium composition and method of bio imagination using the same Grant 9,669,114 - Ahn , et al. June 6, 2	2017-06-06
Drug Carrier Having L-dna Nanocage Structure App 20160287706 - AHN; Dae-Ro	2016-10-06
Drug Carrier Having Self-assembled 3-d Nucleic Acid Nanostructure App 20160051483 - AHN; Dae Ro ; et al.	2016-02-25
Contrast Medium Composition And Method Of Bio Imagination Using The Same App 20140255307 - AHN; Dae Ro ; et al.	2014-09-11
Modified Nucleotide And Real-time Polymerase Reaction Using The Same App 20120064531 - AHN; Dae-Ro	2012-03-15
3'-o-fluorescently modified nucleotides and uses thereof Grant 8,030,466 - Shin , et al. October 4, 2	2011-10-04
3'-o-fluorescently Modified Nucleotides And Uses Thereof App 20110076679 - SHIN; Dongyun ; et al.	2011-03-31
Antigen Detection Kit and Method App 20110027772 - AHN; Dae-Ro ; et al.	2011-02-03
Method for quantitative analysis of interactions between HIF-1alpha C-terminal peptides and CBP or p300 proteins and method of screening inhibitors using the same Grant 7,816,094 - Yang , et al. October 19, 2	2010-10-19
Plasmid For Expressing Thioredoxin Fusion Protein And Method For Producing Target Protein Using Same App 20100184146 - Ahn; Hee-Chul ; et al.	2010-07-22
Method and kit for detecting a target protein using a DNA aptamer Grant 7,642,056 - Ahn , et al. January 5, 2	2010-01-05
METHOD FOR QUANTITATIVE ANALYSIS OF INTERACTIONS BETWEEN HIF-1ALPHA C-TERMINAL PEPTIDES AND CBP OR p300 PROTEINS AND METHOD OF SCREENING INHIBITORS USING THE SAME App 20090029390 - YANG; Eun-Gyeong ; et al.	2009-01-29
Method And Kit For Detecting A Target Protein Using A Dna Aptamer App 20080261225 - AHN; Dae-Ro ; et al.	2008-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.